Perform Another (Advanced) Search

1.  Study Posting (4114) Trial #157046, Osteoarthritis, Aventura, FL
...Trial Information Study of patients with Osteoarthritis and Rheumatoid Arthritis with a high risk of cardiovascular disease comparing the efficacy and safety of a study medication with other study medications. Evaluation of ...
View Page

2.  Study Posting (4114) Trial #157047, Rheumatoid Arthritis, Aventura, FL
...Trial Information Study of patients with Osteoarthritis and Rheumatoid Arthritis with a high risk of cardiovascular disease comparing the efficacy and safety of a study medication with other study medications. Evaluation of ...
View Page

3.  Study Posting (4519) Trial #161512, Diabetes Mellitus, Type 2, Trencin, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

4.  Study Posting (4519) Trial #161544, Diabetes Mellitus, Type 2, Prievidza, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

5.  Study Posting (4519) Trial #161546, Diabetes Mellitus, Type 2, Lucenec, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

6.  Study Posting (4519) Trial #161526, Diabetes Mellitus, Type 2, Levice, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

7.  Study Posting (4519) Trial #161545, Diabetes Mellitus, Type 2, Komarno, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

8.  Study Posting (4519) Trial #161479, Diabetes Mellitus, Type 2, Bratislava, Slovakia
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

9.  Study Posting (4519) Trial #161477, Diabetes Mellitus, Type 2, Vilnius, Lithuania
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

10.  Study Posting (4519) Trial #161485, Diabetes Mellitus, Type 2, Klaipeda, Lithuania
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

11.  Study Posting (4519) Trial #161486, Diabetes Mellitus, Type 2, Kaunas, Lithuania
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

12.  Study Posting (4519) Trial #161535, Diabetes Mellitus, Type 2, Alytus, Lithuania
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

13.  Study Posting (4519) Trial #161541, Diabetes Mellitus, Type 2, Urhida, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

14.  Study Posting (4519) Trial #161543, Diabetes Mellitus, Type 2, Szikszo, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

15.  Study Posting (4519) Trial #161530, Diabetes Mellitus, Type 2, Sopron, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

16.  Study Posting (4519) Trial #161540, Diabetes Mellitus, Type 2, Mako, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

17.  Study Posting (4519) Trial #161542, Diabetes Mellitus, Type 2, Komarom, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

18.  Study Posting (4519) Trial #161523, Diabetes Mellitus, Type 2, Hodmezovasarhely, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

19.  Study Posting (4519) Trial #161507, Diabetes Mellitus, Type 2, Gyula, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

20.  Study Posting (4519) Trial #161458, Diabetes Mellitus, Type 2, Debrecen, Hungary
...Information A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status: Recruiting Protocol Number: NC25113 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page